The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials.
about
Anakinra for rheumatoid arthritisEffects of glucocorticoids on radiological progression in rheumatoid arthritisComparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION studyValidation of the Rheumatoid and Arthritis Outcome Score (RAOS) for the lower extremityA rational use of glucocorticoids in patients with early arthritis has a minimal impact on bone mass.Perceived need to take medication is associated with medication non-adherence in patients with rheumatoid arthritis.Capsaicin-sensitive sensory nerves exert complex regulatory functions in the serum-transfer mouse model of autoimmune arthritis.Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.Rheumatoid arthritis in 2003: where are we now with treatment?Progression of radiographic joint damage in different eras: trends towards milder disease in rheumatoid arthritis are attributable to improved treatmentPrediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope.Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score.Transient receptor potential ankyrin 1 (TRPA1) receptor is involved in chronic arthritis: in vivo study using TRPA1-deficient mice.Leflunomide-related lung injury in patients with rheumatoid arthritis: imaging features.Lack of Galanin 3 Receptor Aggravates Murine Autoimmune Arthritis.Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis.Rheumatoid arthritis--early diagnosis and disease managementTrends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohortA clinical exploratory study with itolizumab, an anti-CD6 monoclonal antibody, in patients with rheumatoid arthritis.A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis.Tocilizumab: a review of its safety and efficacy in rheumatoid arthritis.Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature.Can bone loss in rheumatoid arthritis be prevented?Pharmacogenetic biomarkers for predicting drug response.Inhibition of tumour necrosis factor and IL-17 production by leflunomide involves the JAK/STAT pathwaySulfasalazine reduces bile acid induced apoptosis in human hepatoma cells and perfused rat livers.Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients.Effect of biologic therapy on radiological progression in rheumatoid arthritis: what does it add to methotrexate?Tumor necrosis factor-α inhibits chondrogenic differentiation of synovial fibroblasts through p38 mitogen activating protein kinase pathways.New insights and long-term safety of tocilizumab in rheumatoid arthritisThe C677T polymorphism in theMTHFRgene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population
P2860
Q24241707-FEECB294-4040-43B8-AE1E-892DF97B4901Q24243070-305B7065-AAD7-41AF-A00E-FFEF420AA5D2Q24630541-07D66F14-AF24-40D7-AA89-CF2BABFDF550Q24798133-952F0CD4-4BD8-4417-81B7-461264DF7320Q33923332-EA11BF7E-C3D4-4830-A8A0-2412847D9C2CQ34730116-16918EAC-0869-4909-B3D7-7BF968A7E9CEQ35146980-07F04920-B2F5-48E7-8F83-389DB4942B0FQ35237316-016E9ADB-07FF-4042-A1C1-039FBB715C65Q35553548-9B9A22CB-9B9F-4977-81BA-1D1523690BA6Q35637812-5697739A-06F3-445B-B42F-E6F8DE6734F0Q35760017-5464C748-5625-4DAB-AC99-452DC8CE8CA1Q36013828-A24E18CE-DDBF-4DA6-BE69-C8B88D05ADB7Q36477409-942513B3-F3B3-4853-B88F-7FE9110ABF76Q36618003-94093464-90F6-400A-B0A1-A29D5FD955D8Q36945678-899E3E01-76BF-4620-AD9A-E28CD8DD0651Q36975907-82D1F0E0-1E64-44F7-B1A4-DC6722D6CFCFQ37043713-AC974C59-7317-439F-8091-9B50B832E26BQ37129582-17AA8E52-8161-48E7-85C4-DFBC0D81EC92Q37390483-C8366B69-DBBB-4C4D-A72E-63FD75379B1AQ37546519-17A8033E-DE38-4612-A794-754D090B1FB5Q37828398-A67FAC40-66E4-4313-A59E-25E6AB5CEF0BQ38011225-5ABB0655-AE97-4955-B53B-A29F7459E950Q38115190-5E52DA85-E390-4A32-BF52-8A0766EE5863Q38214388-C036A52D-22EA-4673-8DB9-E6C95CB79A43Q39924118-5E2D97DA-27BA-401D-85C6-18A3867E1D73Q40345193-B8FEF56C-80CF-411D-93EB-0E1936FEF0CBQ41723056-CB3628AA-4C9F-4AEB-90E4-3A3B9C20113AQ42245160-76ACAC5E-FEA8-437B-B5F0-D237AC8C512DQ47888590-CD60B1E6-884D-44A7-9781-1E1FBB57DE48Q57482184-BF7FA51F-D78A-41CC-BACC-8508AD441651Q58912366-16A25B61-9DB8-4715-B7BD-362BE3B9E3EA
P2860
The effect of treatment on radiological progression in rheumatoid arthritis: a systematic review of randomized placebo-controlled trials.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The effect of treatment on rad ...... zed placebo-controlled trials.
@ast
The effect of treatment on rad ...... zed placebo-controlled trials.
@en
type
label
The effect of treatment on rad ...... zed placebo-controlled trials.
@ast
The effect of treatment on rad ...... zed placebo-controlled trials.
@en
prefLabel
The effect of treatment on rad ...... zed placebo-controlled trials.
@ast
The effect of treatment on rad ...... zed placebo-controlled trials.
@en
P2093
P356
P1433
P1476
The effect of treatment on rad ...... ized placebo-controlled trials
@en
P2093
P356
10.1093/RHEUMATOLOGY/KEG036
P50
P577
2003-01-01T00:00:00Z